TERUMO AORTIC ANNOUNCES US FDA BREAKTHROUGH DEVICE DESIGNATION FOR FENESTRATED TREO®
Archive of Terumo Group's news releases, highlighting the latest in Terumo updates.
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
Archive of Terumo Group's news releases, highlighting the latest in Terumo updates.
Source route
Continue on terumo.com
Leave the platform to read the original full article on the publisher site.
Source: Terumo Global
Scope: Devices
Related coverage
More related coverage
Danaher Schedules First Quarter 2026 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference cal...
Financial calendar
Siemens Healthineers AG Investor Relations events calendar provides information on upcoming and past...
Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing on Quantum Flex
Archive of Terumo Group's news releases, highlighting the latest in Terumo updates.
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
SAN DIEGO , March 18, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a g...